📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. (2012)

First Author: Boumans MJ

Attributed to: Centre for Musculoskeletal Ageing Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2011-200198

PubMed Identifier: 22072013

Publication URI: http://europepmc.org/abstract/MED/22072013

Type: Journal Article/Review

Volume: 71

Parent Publication: Annals of the rheumatic diseases

Issue: 1

ISSN: 0003-4967